A carregar...
HDAC1 Silencing in Ovarian Cancer Enhances the Chemotherapy Response
Background/Aims: Cisplatin-based treatment is first-line chemotherapy for several cancers including ovarian cancer. The development of cisplatin resistance results in treatment failure, but the underlying mechanisms are not fully understood. Histone deacetylases (HDACs) are a large family of enzymes...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Cell Physiol Biochem Press GmbH & Co KG
2018-08-01
|
| Colecção: | Cellular Physiology and Biochemistry |
| Assuntos: | |
| Acesso em linha: | https://www.karger.com/Article/FullText/492260 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|